Harnessing aptamers against COVID-19: A therapeutic strategy.

ABSTRACT: The novel coronavirus crisis caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) was a global pandemic. Although various therapeutic approaches were developed over the past 2 years, novel strategies with more efficient applicability are required to target new variants. Aptamers are single-stranded (ss)RNA or DNA oligonucleotides capable of folding into unique 3D structures with robust binding affinity to a wide variety of targets following structural recognition. Aptamer-based theranostics have proven excellent capability for diagnosing and treating various viral infections. Herein, we review the current status and future perspective of the potential of aptamers as COVID-19 therapies.

SUBMITTER: Mahmoudi A 

PROVIDER: S-EPMC10266562 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature